MYDA Advisors’s Biodesix BDSX Stock Holding History

MYDA Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,500	Closed	-$76.5K	–	148
2024 Q4	$76.5K	Buy	+2,500	New	+$73.6K	0.02%	129

Other funds holding BDSX

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MYDA Advisors's BDSX Position: Q1 2025 in Review

MYDA Advisors sold out of Biodesix (BDSX) in Q1 2025, closing a stake of 2,500 shares — an estimated $76.5K sold.

MYDA Advisors first reported a position in BDSX in Q4 2024 and held it in 1 quarter. The position peaked at $76.5K in Q4 2024. 59 funds tracked by Wall St. Rank hold BDSX as of Q1 2025.

MYDA Advisors reported no remaining Biodesix position as of Q1 2025 after selling out during the quarter.
MYDA Advisors sold 2,500 Biodesix shares in Q1 2025, an estimated $76.5K.
MYDA Advisors first reported a position in Biodesix in Q4 2024 and held it in 1 quarter.
MYDA Advisors's Biodesix position peaked at $76.5K in Q4 2024.
59 funds tracked by Wall St. Rank held Biodesix as of Q1 2025.

Based on MYDA Advisors's 13F filing for Q1 2025, filed 14 May 2025.